论文部分内容阅读
目的观察依达拉奉治疗急性脑梗死的疗效。方法将60例急性脑梗死患者随机分为依达拉奉组、奥扎格雷钠组(治疗组)和奥扎格雷纳与复方丹参组(对照组)各30例,对两组治疗前后神经功能缺损进行评分。结果治疗组显效率为76.6%,对照组为43.3%。治疗组明显优于对照组(P<0.01)。结论依达拉率治疗急性脑梗死安全有效。
Objective To observe the therapeutic effect of edaravone on acute cerebral infarction. Methods Sixty patients with acute cerebral infarction were randomly divided into edaravone group, ozagrel sodium group (treatment group) and Ozagrenault group and compound salvia miltiorrhiza group (control group), 30 patients in each group. Before and after treatment, neurological function Defects were scored. Results The effective rate was 76.6% in the treatment group and 43.3% in the control group. The treatment group was significantly better than the control group (P <0.01). Conclusion It is safe and effective to treat acute cerebral infarction with edara rate.